IL6 and breast carcinoma: To our knowledge, we are the first to report physiological consequences of breast cancer cells that have high CRYβB2 expression including increased tumor proliferation, IL6 secretion, enhanced metastatic homing to the liver, increased expression of metastatic and EMT-associated genes, and invasive cellular behaviors.